Glucose uptake in dilated small intestine.
OBJECTIVE
The development of dilated small intestine in patients with short bowel syndrome results in increased mucosal surface area. This study examines whether the incremental increase in surface area leads to a proportional increase in absorptive function of the small intestine.


METHODS
Partial obstruction of the small intestine was created in rats by placing an intussusception valve in the proximal jejunum. Rats that underwent sham operations served as controls. One week postoperatively, the small intestine proximal and distal to the valve was removed. The intestinal diameter proximal and distal to the obstruction was measured. The rate of glucose uptake was measured by the everted sleeve technique. The results were analyzed by analysis of variance (ANOVA).


RESULTS
The intestine proximal to the valve was significantly dilated and thickened when compared with the intestine distal to the valve. The wet mass per centimeter of the dilated segment was 2.5 times that of the control group (P<.001). The glucose uptake capacity of the dilated segment was slightly higher than that of the control group (540 v 420 nmol/min/cm, P<.05). However, the specific glucose uptake rate was reduced significantly in the intestine proximal to the valve (247 v 335 nmol/min/cm2, P<.01).


CONCLUSIONS
Although the partial obstruction of small intestine resulted in a substantial increase in the intestinal surface area, the absorptive capacity of the dilated intestine per unit surface area was decreased significantly. This translated ultimately into a slight increase in the overall functional absorptive capacity of glucose in the small intestine. These results suggest that dilated small intestine may not enhance mucosal absorption.
Kawaguchi
A L
AL
Division of Pediatric Surgery, UCLA School of Medicine, Los Angeles, California 90095, USA.
Dunn
J C
JC
Lam
M
M
O'Connor
T P
TP
Diamond
J
J
Fonkalsrud
E W
EW
D000704:Analysis of Variance; D000818:Animals; D004108:Dilatation, Pathologic / Q000378:metabolism; D004195:Disease Models, Animal; D005947:Glucose / Q000378:metabolism* / Q000493:pharmacokinetics; D007408:Intestinal Absorption / Q000502:physiology*; D007415:Intestinal Obstruction / Q000378:metabolism* / Q000601:surgery; D007421:Intestine, Small / Q000378:metabolism* / Q000601:surgery; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values
D005947:Glucose